Evaluation of the Effectiveness of the HPV Education Program Applied to Women

NCT07468487 | Completed

• 1 other identifier: 10.01.2024/172
• Study Type: interventional
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to evaluate the effectiveness of an educational program conducted by nurses on Human Papilloma Virus and its effects on women's health in women of reproductive age. Data were collected from women aged 30-49 with active sexual lives using a Descriptive Information Form and the HPV Knowledge Scale, and then analyzed and interpreted.

Conditions

HIV (Human Immunodeficiency Virus)

Keywords

HIV; education; Health Promotion Model; Reproductive Health

Outcome Measures

Primary Outcomes (1)

• "Scale for Determining the Reproductive Health Preventive Attitudes of Married Women"

  The Reproductive Health Protective Attitudes Scale for Married Women is a Likert-type scale consisting of 39 items, scored from 1 to 5. The total raw score obtained by summing the 39 items ranges from 39 to 195. It has five sub-dimensions. Higher total and sub-dimension scores indicate more positive attitudes and behaviors towards protecting women's reproductive health.

  Up to 6 months

Study Arms (2)

Education Group

EXPERIMENTAL

This group will be trained using Pender's Health Promotion Model.

Behavioral: Reproductive health education program

Control

NO INTERVENTION

This group will not receive training; only assessments will be conducted.

Interventions

Reproductive health education program BEHAVIORAL

Reproductive health education program prepared using Pender's Health Promotion Model.

Education Group

Eligibility Criteria

• Age: 18 Years - 49 Years
• Gender Eligibility Details: Pregnant women, women with disabilities, and transgender individuals were not included in the study.
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Female individuals Having been diagnosed with HIV Being between 18-49 years of age Being sexually active

You may not qualify if:

• Being pregnant
• Being postpartum
• Disabled individuals
• Individuals whose gender identity does not match their biological sex at birth, those receiving hormonal therapy, or other conditions that do not fit the specific biological focus of the study.

Sponsors & Collaborators

• Okan University: lead

Study Sites (1)

Istanbul Okan University

Tuzla, Istanbul, 34843, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Study Officials

• Ozlem Akgol, Asst. Professor

  Okan University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: no masking
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Asistant Professor

Model Details: Our study will be conducted using an "Experimental Group" that will receive training and a "Control Group" that will not receive any training.

Study Record Dates

• First Submitted: February 13, 2026
• First Posted: March 12, 2026
• Study Start: March 25, 2024
• Primary Completion: September 25, 2024
• Study Completion: January 14, 2025
• Last Updated: March 17, 2026

Record last verified: 2026-03

Locations

TU (1)